Preventing familial breast and ovarian cancer: Major research advances with little implication

Women's Health

Volumn 7, Issue 2, 2011, Pages 135-138

  Ziogas, Dimosthenis E ^a   Katsios, Christos S ^a   Roukos, Dimitrios H ^a,b  

^a UNIVERSITY OF IOANNINA   (Greece)

^b UNIVERSITY OF IOANNINA   (Greece)

Author keywords

BRCA1 2 mutations; familial breast ovarian cancer; missing heritability; prevention

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

BREAST CANCER; CANCER GENETICS; CANCER PREVENTION; CANCER RISK; ENVIRONMENTAL FACTOR; EXOME; FAMILIAL CANCER; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC SCREENING; GENETIC VARIABILITY; HERITABILITY; HUMAN; OVARY CANCER; PERSONALIZED MEDICINE; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

BREAST NEOPLASMS; DECISION MAKING; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MUTATION; NEOPLASTIC SYNDROMES, HEREDITARY; OVARIAN NEOPLASMS;

EID: 79952809672     PISSN: 17455057     EISSN: 17455065     Source Type: Journal    
DOI: 10.2217/whe.11.8     Document Type: Review

References (21)

1. Feero WG, Guttmacher AE, Collins FS: Genomic medicine-an updated primer. N Engl. J. Med. 362(21), 2001-2011 (2010).
2. Hamburg MA, Collins FS: The path to personalized medicine. N Engl. J. Med. 363(4), 301-304 (2010).
3. Yoshida K, Miki Y: Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage. Cancer Sci. 95(11), 866-871 (2004). (Pubitemid 40045520)
4. Stratton MR, Rahman N: The emerging landscape of breast cancer susceptibility. Nat Genet. 40(1), 17-22 (2008).
5. Politopoulos I, Gibson J, Tapper W, Ennis S, Eccles D, Collins A: Genome-wide association of breast cancer: composite likelihood with imputed genotypes. Eur. J. Hum. Genet. 19(2), 194-199 (2011).
6. Pharoah PD, Antoniou A, Bobrow M, Zimmern RL, Easton DF, Ponder BA: Polygenic susceptibility to breast cancer and implications for prevention. Nat. Genet. 31(1), 33-36 (2002).
7. Altshuler DM, Gibbs RA, Peltonen L et al.; International HapMap 3 Consortium: Integrating common and rare genetic variation in diverse human populations. Nature 467(7311), 52-58 (2010).
8. Manolio TA: Genomewide association studies and assessment of the risk of disease. N Engl. J. Med. 363(2), 166-176 (2010).
9. Wacholder S, Hartge P, Prentice R et al.: Performance of common genetic variants in breast-cancer risk models. N Engl. J. Med. 362(11), 986-993 (2010).
10. Manolio TA, Collins FS, Cox NJ: Finding the missing heritability of complex diseases. Nature 461(7265), 747-753 (2009).
11. Baker M: Genomics: the search for association. Nature 467(7319), 1135-1138 (2010).
12. Blaxter M: Genetics. Revealing the dark matter of the genome. Science 330(6012), 1758-1759 (2010).
13. Roy S, Ernst J, Kharchenko PV et al.; modENCODE Consortium: Identifcation of functional elements and regulatory circuits by Drosophila modENCODE. Science 330(6012), 1787-1797 (2010).
14. Gerstein MB, Lu ZJ, Van Nostrand EL et al.: Integrative analysis of the Caenorhabditis elegans genome by the modENCODE project. Science 330(6012), 1775-1787 (2010).
15. Hudson TJ, Anderson W, Artez A et al.; International Cancer Genome Consortium: International network of cancer genome projects. Nature 464, 993-998 (2010).
16. Alberts B: Model organisms and human health. Science 330(6012), 1724 (2010).
17. Domchek SM, Friebel TM, Singer CF et al.: Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA 304(9), 967-975 (2010).
18. Narod SA, Offt K: Prevention and management of hereditary breast cancer. J. Clin. Oncol. 23(8), 1656-1663 (2005). (Pubitemid 46211420)
19. Collaborative Group on Hormonal Factors in Breast Cancer: Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease. Lancet 358(9291), 1389-1399 (2001).
20. Travis RC, Reeves GK, Green J et al.; Million Women Study Collaborators: Gene-environment interactions in 7610 women with breast cancer: prospective evidence from the Million Women Study. Lancet 375(9732), 2143-2151 (2010).
21. Metcalfe KA, Finch A, Poll A et al.: Breast cancer risks in women with a family history of breast or ovarian cancer who have tested negative for a BRCA1 or BRCA2 mutation. Br. J. Cancer. 100(2), 421-425 (2009).